Samir Elian

Publications (4) View all

• Source

  Available from: Paulo Filemon Paolucci Pimenta

  Article: Inhibition of tissue inflammation and bacterial translocation as ones of the protective mechanisms of Saccharomyces boulardii against Salmonella infection in mice.

  Flaviano S Martins, Angélica T Vieira, Samir D A Elian, Rosa M E Arantes, Fabiana C P Tiago, Lirlândia P Sousa, Helena R C Araújo, Paulo F Pimenta, Cláudio A Bonjardim, Jacques R Nicoli, Mauro M Teixeira
  [show abstract] [hide abstract]
  ABSTRACT: Growing evidences suggest that Saccharomyces boulardii (SB) is efficacious against bacterial infections and inflammatory bowel diseases. This study investigated the effects of treatment with SB provided in a murine model of typhoid fever. Mice were divided into two groups: (1) control animals challenged with Salmonella Typhimurium (ST), and (2) animals receiving SB, and then challenged with ST. At days 0, 1, 5, 10 and 15 post-challenge, animals were euthanized and tissues collected to analyze bacterial translocation, cytokines, signaling pathways and histological analysis. Survival rate and animal weight were also evaluated. Treatment with SB increased survival rate and inhibited translocation of bacteria after ST challenge. Histological data showed that SB also protected mice against liver damage induced by ST. SB decreased levels of inflammatory cytokines and activation of mitogen-activated protein kinases (p38, JNK and ERK1/2), phospho-IκB, p65-RelA, phospho-jun and c-fos in the colon, signal pathways involved in the activation of inflammation induced by ST. Further experiments revealed that probiotic effects were due, at least in part, to the binding of ST to the yeast. Such binding diminishes ST translocation, resulting in decreased activation of signaling pathways which lead to intestinal inflammation in a murine model of typhoid fever.
  Microbes and Infection 01/2013; · 3.10 Impact Factor
• Source

  Available from: Samir Elian

  Article: Oral treatment with Saccharomyces cerevisiae strain UFMG 905 modulates immune responses and interferes with signal pathways involved in the activation of inflammation in a murine model of typhoid fever.

  Flaviano S Martins, Samir D A Elian, Angélica T Vieira, Fabiana C P Tiago, Ariane K S Martins, Flávia C P Silva, Ericka L S Souza, Lirlândia P Sousa, Helena R C Araújo, Paulo F Pimenta, Cláudio A Bonjardim, Rosa M E Arantes, Mauro M Teixeira, Jacques R Nicoli
  [show abstract] [hide abstract]
  ABSTRACT: Salmonella spp. are Gram-negative, facultative, intracellular pathogens that cause several diarrheal diseases ranging from self-limiting gastroenteritis to typhoid fever. Previous results from our laboratory showed that Saccharomyces cerevisiae strain UFMG 905 isolated from 'cachaça' production presented probiotic properties due to its ability to protect against experimental infection with Salmonella enterica serovar Typhimurium. In this study, the effects of oral treatment with S. cerevisiae 905 were evaluated at the immunological level in a murine model of typhoid fever. Treatment with S. cerevisiae 905 inhibited weight loss and increased survival rate after Salmonella challenge. Immunological data demonstrated that S. cerevisiae 905 decreased levels of proinflammatory cytokines and modulated the activation of mitogen-activated protein kinases (p38 and JNK, but not ERK1/2), NF-κB and AP-1, signaling pathways which are involved in the transcriptional activation of proinflammatory mediators. Experiments in germ-free mice revealed that probiotic effects were due, at least in part, to the binding of Salmonella to the yeast. In conclusion, S. cerevisiae 905 acts as a potential new biotherapy against S. Typhimurium infection due to its ability to bind bacteria and modulate signaling pathways involved in the activation of inflammation in a murine model of typhoid fever.
  International journal of medical microbiology: IJMM 01/2011; 301(4):359-64. · 2.80 Impact Factor
• Source

  Available from: Samir Elian

  Article: Evaluation of in vitro antagonism and of in vivo immune modulation and protection against pathogenic experimental challenge of two probiotic strains of Bifidobacterium animalis var. lactis.

  Ariane K S Martins, Flaviano S Martins, Danielle A Gomes, Samir D A Elian, Angélica T Vieira, Mauro M Teixeira, Denise C Cara, Regina M D Nardi, Jacques R Nicoli
  [show abstract] [hide abstract]
  ABSTRACT: The aim of the present study was to compare the effect of intragastric administration with two strains of Bifidobacterium animalis subsp. lactis (Bifido A and Bifido B), in gnotobiotic and conventional mice, challenged with Salmonella Typhimurium. In vitro antagonism test showed that the two strains were able to produce antagonistic substances against various pathogenic microorganisms. In an ex vivo antagonism test the production of antagonistic substances was observed only against three out ten pathogens tested. Both Bifidobacterium strains were able to colonize and to maintain high population levels in the digestive tract of gnotobiotic mice. In addition, the two strains had low and limited translocation ability and did not cause any histological lesion in any of the organs analyzed. Both strains were able to reduce the fecal number of Salmonella in gnotobiotic mice challenged with the pathogen, but only Bifido B was able to confer a protection as demonstrated by a lower mortality. Higher levels of sIgA and IL-10 were observed only in Bifido B mono-associated mice when compared to germ free group. We could conclude that, among the parameters analyzed, the strain Bifido B exhibited the more desirable characteristics to be used as a probiotic.
  Archives of Microbiology 12/2010; 192(12):995-1003. · 1.43 Impact Factor
• Article: Oral treatment with Saccharomyces cerevisiae strain UFMG 905 modulates immune responses and interferes with signal pathways involved in the activation of inflammation in a murine model of typhoid fever

  Flaviano S. Martins, Samir D.A. Elian, Angélica T. Vieira, Fabiana C.P. Tiago, Ariane K.S. Martins, Flávia C.P. Silva, Éricka L.S. Souza, Lirlândia P. Sousa, Helena R.C. Araújo, Paulo F. Pimenta, Cláudio A. Bonjardim, Rosa M.E. Arantes, Mauro M. Teixeira, Jacques R. Nicoli
  [show abstract] [hide abstract]
  ABSTRACT: Salmonella spp. are Gram-negative, facultative, intracellular pathogens that cause several diarrheal diseases ranging from self-limiting gastroenteritis to typhoid fever. Previous results from our laboratory showed that Saccharomyces cerevisiae strain UFMG 905 isolated from ‘cachaça’ production presented probiotic properties due to its ability to protect against experimental infection with Salmonella enterica serovar Typhimurium. In this study, the effects of oral treatment with S. cerevisiae 905 were evaluated at the immunological level in a murine model of typhoid fever. Treatment with S. cerevisiae 905 inhibited weight loss and increased survival rate after Salmonella challenge. Immunological data demonstrated that S. cerevisiae 905 decreased levels of proinflammatory cytokines and modulated the activation of mitogen-activated protein kinases (p38 and JNK, but not ERK1/2), NF-κB and AP-1, signaling pathways which are involved in the transcriptional activation of proinflammatory mediators. Experiments in germ-free mice revealed that probiotic effects were due, at least in part, to the binding of Salmonella to the yeast. In conclusion, S. cerevisiae 905 acts as a potential new biotherapy against S. Typhimurium infection due to its ability to bind bacteria and modulate signaling pathways involved in the activation of inflammation in a murine model of typhoid fever.
  International Journal of Medical Microbiology.